Overview
- 197 inspections across 188 sites are on record.
- 336 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
197
Sites
188
Observations
336
Career since
Jan 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Strides Pharma Science Limited | 20 May 2026 | Human Drugs | On file |
| USV Private Limited | 17 Apr 2026 | Human Drugs | On file |
| Lupin Limited | 7 Mar 2026 | Human Drugs | On file |
| Eugia Pharma Specialities Limited | 6 Feb 2026 | Human Drugs | View 483 → |
| Zydus Lifesciences Limited | 23 Jan 2026 | Human Drugs | On file |
Sites inspected
Strides Pharma Science LimitedBangalore, India1 insp.
USV Private LimitedDabhel, Daman, India1 insp.
Lupin LimitedAnkleshwar, India1 insp.
Eugia Pharma Specialities LimitedSangareddy, India1 insp.
Zydus Lifesciences LimitedAnkleshwar, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Chad W Rice16 shared
Kevin A Beavers13 shared
Rafeeq A Habeeb7 shared
Michelle C Webb6 shared
Robert J Ham5 shared
Jill J Tillman4 shared
Ashlee M Ward4 shared
Rendall E Barfoot4 shared
Lisa W Flores4 shared
Monica E Murie3 shared
Full investigator report
Get the verbatim findings behind Lisa L Flores' 336 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site